Non-Randomized Controlled Trials as Topic
"Non-Randomized Controlled Trials as Topic" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Works about a study where participants are assigned to a treatment, procedure, or intervention by methods that are not random. Non-randomized clinical trials are sometimes referred to as quasi-experimental clinical trials or non-equivalent control group designs.
| Descriptor ID |
D065228
|
| MeSH Number(s) |
E05.318.760.250.500.365.250 N05.715.360.775.088.500.387.250 N06.850.520.450.250.250.365.250
|
| Concept/Terms |
Non-Randomized Controlled Trials as Topic- Non-Randomized Controlled Trials as Topic
- Non Randomized Controlled Trials as Topic
- Controlled Clinical Trials, Non-Randomized
- Controlled Clinical Trials, Non Randomized
- Quasi-Experimental Studies
- Quasi Experimental Studies
- Quasi-Experimental Study
- Studies, Quasi-Experimental
- Study, Quasi-Experimental
- Clinical Trials, Nonrandomized
- Clinical Trial, Nonrandomized
- Nonrandomized Clinical Trial
- Nonrandomized Clinical Trials
- Trial, Nonrandomized Clinical
- Trials, Nonrandomized Clinical
- Controlled Clinical Trials, Nonrandomized
- Clinical Trials, Non-Randomized
- Clinical Trial, Non-Randomized
- Clinical Trials, Non Randomized
- Non-Randomized Clinical Trial
- Non-Randomized Clinical Trials
- Trial, Non-Randomized Clinical
- Trials, Non-Randomized Clinical
- Nonrandomized Controlled Trials as Topic
|
Below are MeSH descriptors whose meaning is more general than "Non-Randomized Controlled Trials as Topic".
Below are MeSH descriptors whose meaning is more specific than "Non-Randomized Controlled Trials as Topic".
This graph shows the total number of publications written about "Non-Randomized Controlled Trials as Topic" by people in this website by year, and whether "Non-Randomized Controlled Trials as Topic" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2017 | 1 | 2 | 3 |
| 2019 | 0 | 3 | 3 |
| 2020 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Non-Randomized Controlled Trials as Topic" by people in Profiles.
-
The quantra hemostasis analyzer compared to thromboelastography (TEG) in the surgical oncologic population: A prospective observational trial. J Surg Oncol. 2021 Oct; 124(5):894-905.
-
Phase I Study of Everolimus, Letrozole, and Trastuzumab in Patients with Hormone Receptor-positive Metastatic Breast Cancer or Other Solid Tumors. Clin Cancer Res. 2021 03 01; 27(5):1247-1255.
-
Characteristics of the Multiplicity of Randomized Clinical Trials for Coronavirus Disease 2019 Launched During the Pandemic. JAMA Netw Open. 2020 07 01; 3(7):e2015100.
-
Outcomes of a novel upper extremity preloaded delivery system for fenestrated-branched endovascular repair of thoracoabdominal aneurysms. J Vasc Surg. 2020 08; 72(2):470-479.
-
Improving the quality of maternal and newborn health outcomes through a clinical mentorship program in the Democratic Republic of the Congo: study protocol. Reprod Health. 2019 Oct 10; 16(1):147.
-
Clinical Experience With Ibrutinib Alone or in Combination With Either Cytarabine or Azacitidine in Patients With Acute Myeloid Leukemia. Clin Lymphoma Myeloma Leuk. 2019 08; 19(8):509-515.e1.
-
Survival to hospital discharge with biphasic fixed 360 joules versus 200 escalating to 360 joules defibrillation strategies in out-of-hospital cardiac arrest of presumed cardiac etiology. Resuscitation. 2019 03; 136:112-118.
-
Technical aspects and 30-day outcomes of the prospective early feasibility study of the GORE EXCLUDER Thoracoabdominal Branched Endoprosthesis (TAMBE) to treat pararenal and extent IV thoracoabdominal aortic aneurysms. J Vasc Surg. 2019 08; 70(2):358-368.e6.
-
T-Cell-Inflamed Gene-Expression Profile, Programmed Death Ligand 1 Expression, and Tumor Mutational Burden Predict Efficacy in Patients Treated With Pembrolizumab Across 20 Cancers: KEYNOTE-028. J Clin Oncol. 2019 02 01; 37(4):318-327.
-
Reported obstructive sleep apnea does not diminish the cardiometabolic health benefits from a comprehensive lifestyle intervention program. J Clin Hypertens (Greenwich). 2018 11; 20(11):1610-1614.